MeSH D019967 - schizophrenia spectrum and other psychotic disorders
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D001523:Mental disorders
0 Companies
0 Drugs
Success rate
D019967:Â
Schizophrenia spectrum and other psychotic disorders
D000341:Psychotic affective disorders
D002194:Capgras syndrome
0 Companies
0 Drugs
Success rate
D010259:Paranoid disorders
0 Companies
0 Drugs
Success rate
D011618:Psychotic disorders
D012559:Schizophrenia
D055535:Morgellons disease
0 Companies
0 Drugs
Success rate
D063726:Delusional parasitosis
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Accord Healthcare | Aripiprazole | Aripiprazole |  | 2016-12-07 |  |  |
| Aripiprazole | Aripiprazole Accord |  | 2015-11-15 |  |  | |
| Clozapine | Clozapine |  | 2015-11-25 |  |  | |
| Quetiapine | Quetiapine |  | 2016-11-01 |  |  | |
| Ajanta Pharma | Aripiprazole | Aripiprazole |  | 2016-09-12 |  |  |
| Olanzapine | Olanzapine |  | 2017-05-30 |  |  | |
| Risperidone | Risperidone |  | 2011-08-24 |  |  | |
| Alembic Pharmaceuticals | Aripiprazole | Aripiprazole |  | 2015-04-28 |  |  |
| Asenapine | Asenapine |  | 2020-12-10 |  |  | |
| Quetiapine | Quetiapine |  | 2014-10-28 |  |  | |
| Alkem Laboratories | Aripiprazole | Aripiprazole |  | 2019-02-21 |  |  |
| Olanzapine | Olanzapine |  | 2015-10-20 |  |  | |
| Quetiapine | Quetiapine |  | 2013-02-12 |  |  | |
| Alkermes | Aripiprazole lauroxil | Aristada | 2030-06-24 | 2015-10-05 | $326.483 M | Q2/23-Q1/24 |
| Olanzapine, Samidorphan | Lybalvi | 2025-11-23 | 2021-05-28 | $210.905 M | Q2/23-Q1/24 | |
| Allergan | Asenapine | Saphris | 2026-04-06 | 2009-08-13 | $134.4 M | Q2/19-Q1/20 |
| Haloperidol | Haloperidol |  | 1988-05-17 |  |  | |
| Paliperidone | Paliperidone |  | 2015-08-03 |  |  | |
| Quetiapine | Quetiapine |  | 2013-02-27 |  |  | |
| Risperidone | Risperidone |  | 2011-04-19 |  |  | |
| Alpharma | Haloperidol | Haloperidol |  | 1986-04-11 |  |  |
1
2
3
4
5
6
...
12
>
Clinical Trials
Historical Success Rate
Phase 1
67%2/3
Phase 2
33%2/6
Phase 3
100%20/20
Approved: 20Overall Success rate: 22%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
...
8
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use